Decompressive shunts and hepatic encephalopathy

Indian Journal of Gastroenterology

Volumn 22, Issue SUPPL. 2, 2003, Pages

  Sachdev, A ^a,c   Duseja, A ^b  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^c Medicine   (India)

Author keywords

Portal systemic shunts; Transjugular intrahepatic portosystemic shunts

Indexed keywords

ANTIBIOTIC AGENT; CARNITINE; LACTULOSE; ORNITHINE ASPARTATE;

BRAIN DECOMPRESSION; CELL TRANSPLANTATION; CONFERENCE PAPER; DECOMPRESSION SURGERY; DRUG EFFICACY; ENDOPROSTHESIS; HEPATIC ENCEPHALOPATHY; HEPATOCYTE TRANSPLANTATION; HEPATOPETAL BLOOD FLOW; HUMAN; LIVER BLOOD FLOW; MORTALITY; PATHOGENESIS; PORTOSYSTEMIC ANASTOMOSIS; PROTEIN RESTRICTION; SHUNTING; STENT; SURGICAL PORTOSYSTEMIC ANASTOMOSIS;

DECOMPRESSION, SURGICAL; HEPATIC ENCEPHALOPATHY; HUMANS; HYPERTENSION, PORTAL; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; POSTOPERATIVE COMPLICATIONS;

EID: 1442289629     PISSN: 02548860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. Whipple AO. The problem of portal hypertension in relation to the hepatosplenopathies. Ann Surg 1945;122:449.
2. Burroughs AK, McCormick. Prevention of variceal bleeding. Gastroenterol Clin N Am 1992;21:119-47.
3. Jackson FC, Perrin EB, Felix R, Smith AG. A clinical investigation of the portocaval shunt; survival analysis of the therapeutic operation. Ann Surg 1971;174:672-701.
4. Resnick RF, Iber FL, Ishihara AM, Chalmers TC, Zimmerman H. A controlled study of the therapeutic portocaval shunt. Gastroenterology 1974;67:843-57.
5. Reynolds TB, Donoval AJ, Mikkelsen WP, Redeker AG, Turrill FL, Weiner JM. Results of a 12-year randomized trial of portocaval shunt in patients with alcoholic liver disease and bleeding varices. Gastroenterology 1981;80:1005-11.
6. Reuff B, Prandi D, Degos F, Sicot J, Degos JD, Sicot C. A controlled study of therapeutic portocaval shunt in alcoholic cirrhosis. Lancet 1976;i:655-9.
7. Quinn SF, Kim J, Sheley RC. Percutaneous inferior vena cava-to-portal vein shunt (PIPS) using a stent-graft: preliminary results. J Endovasc Ther 2002;9:503-10
8. Sarfeh IJ, Rypins EB, Mason GR. A systematic appraisal of portocaval H-graft diameters. Clinical and hemodynamic perspectives. Ann Surg 1986;204:356-63.
9. Bismuth H, Franco D, Hepp J. Porto-systemic shunt in hepatic cirrhosis. Does the type of shunt decisively influence the clinical result? Ann Surg 1974;179:209-18.
10. Johansen K. Partial portal decompression for variceal hemorrhage. Am J Surg 1989;157:479-82.
11. Fulenwider JT, Nordlinger BM, Millikan WJ, Sones PJ, Warren WD. Portal pseudoperfusion, an angiographic illusion. Ann Surg 1979;189:257-68.
12. Sarfeh IJ, Rypins EB. Partial versus total portocaval shunt in alcoholic cirrhosis: results of a prospective randomized controlled trial. Ann Surg 1994;219:353-61.
13. Collins JC, Rypins EB, Sarfeh IJ. Narrow diameter portocaval shunts for management of variceal bleeding. World J Surg 1994;18:211-5.
14. Warren WD, Zeppa R, Fomon JJ. Selective transplenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg 1967;166:437-55.
15. Inokuchi K. A selective portocaval shunt. Lancet 1968;ii:51-2.
16. Boyer TD, Henderson JM. Portal hypertension and bleeding varices. In: Zakim D, Boyer TD, Eds. Hepatology - A Textbook of Liver Disease. Philadelphia: WB Saunders. 1996: p. 720-63.
17. Conn HO, Resnick RH, Grace ND, Atterbury CE, Horst D, Groszmann RJ, et al. Distal splenorenal shunt versus portal-systemic shunt: current status of a controlled trial. Hepatology 1981;1:151-60.
18. Reichle R, Fahmy W, Galsorkhi M. Prospective comparative clinical trial with distal splenorenal and mesocaval shunts. Am J Surg 1979;137:13-21.
19. Spina GP, Henderson JM, Rikkers LF, Teres J, Burroughs AK, Conn HO. Distal splenorenal shunt versus endoscopic sclerotherapy in the prevention of variceal bleeding. A meta-analysis of 4 randomized clinical trials. J Hepatol 1992;16:338-45.
20. Henderson JM, Gilmore GT, Hooks MA, Galloway JR, Dodson TF, Hood HM. Selective shunt in the management of variceal bleeding in the era of liver transplantation. Ann Surg 1992;216:248-54.
21. Henderson JM, Millikan WJ, Galloway JR, Millikan WJ Jr, Sones PJ, Warren WD. Portoprival collaterals following distal splenorenal shunt: incidence, magnitude, and associated portal perfusion changes. J Hepatol 1985;1:649-61.
22. Ezzat Fa, abu-Elmagd KM, Aly IY, Aly MA, Fathy OM, el-Barbary MH. Distal splenorenal shunt for management of variceal bleeding in patients with schistosomal hepatic fibrosis. Ann Surg 1986;204:566-73.
23. Warren WD, Henderson JM, Millikan WJ, Galambos JT, Bryan FC. Management of variceal bleeding in patients with non-cirrhotic portal vein thrombosis. Ann Surg 1988;207:623-34.
24. Lopes Filho G de J, Haddad CM. Late clinical, biochemical, endoscopic and electroencephalographic evaluation of patients with schistosomal portal hypertension treated with distal splenorenal shunt. Int Surg 1998;83:42-7.
25. Sarin SK, Nundy S. Subclinical encephalopathy after portosystemic shunts in patients with non-cirrhotic portal fibrosis. Liver 1985;5:142-6.
26. Lake JR, Howdle PD. Gastrointestinal haemorrhage and portal hypertension. In: O'Grady J, Lake JR, Howdle PD, Eds. Comprehensive Clinical Hepatology. London: Harcourt Publishers. 2000: p. 6.1-6.12.
27. Sauer P, Hansmann J, Richter GM, Stremmel W, Stiehl A. Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial. Endoscopy 2002;34:690-7
28. Deschenes M, Dufresne MP, Bui B, Bui B, Fenyves D, Spahr L, et al. Predictors of clinical response to transjugular intrahepatic porto-systemic shunt (TIPS) in cirrhotic patients with refractory ascites. Am J Gastroenterol 1999;94:1361-5.
29. Rosado B, Kamath PS. Transjugular intrahepatic portosystemic shunts: An update. Liver Transpl 2003;9:207-17.
30. Wiltfang J, Nolte W, von Heppe J, Bahn E, Pilz J, Hajak G. Sleep disorders and portal-systemic encephalopathy following transjugular intrahepatic portosystemic stent shunt in patients with liver cirrhosis: relation to tryptophan. Adv Exp Med Biol 1999;467:169-76.
31. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-71.
32. Nagele T, Seeger U, Pereira P, Seitz D, Klose U, Kaiser S. MR proton spectroscopy to monitor the concentration changes in cerebral metabolites following a TIPS placement. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1999;170:298-303.
33. Butterworth R. Pathogenesis of hepatic encephalopathy: update on molecular mechanisms. Indian J Gastroenterol 2003;22(Suppl 2):S11-S16.
34. Jalan R, Gooday R, O'Carroll RE, Redhead DN, Elton RA, Hayes PC. A prospective evaluation of changes in neuropsychological and liver function tests following transjugular intrahepatic portosystemic stent-shunt. J Hepatol 1995;23:697-705.
35. Ong JP, Aggarwal A, Krieger D, Easley KA, Karafa MT, Van Lente F, et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med 2003;114:188-93.
36. Madoff DC, Perez-Young IV, Wallace MJ, Skolkin MD, Toombs BD. Management of TIPS-related refractory hepatic encephalopathy with reduced Wallgraft endoprostheses. J Vasc Interv Radiol 2003;14:369-74.
37. Gerbes AL, Waggershauser T, Holl J, Gulberg V, Fischer G, Reiser M. Experiences with novel techniques for reduction of stent flow in transjugular intrahepatic portosystemic shunts. Z Gastroenterol 1998;36:373-7.
38. Vogels BA, Karlsen OT, Mass MA, Bovee WM, Chamuleau RA. L-ornithine vs. L-ornithine-L-aspartate as a treatment for hyperammonenua-induced encephalopathy in rats. J Hepatol 1997;26:174-82.
39. Kircheis G, Wettstein M, Dahl S, Haussinger D. Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy. Metab Brain Dis 2002;17:453-62.
40. Therrien G, Rose C, Butterworth J, Butterworth RF. Protective effect of L-camitine in ammonia precipitated encephalopathy in the portocaval shunted rats. Hepatology 1997;25:551-6.
41. Schumacher IK, Okamoto T, Kim BH, Chowdhury NR, Chowdhury JR, Fox IJ. Transplantation of conditionally immortalized hepatocytes to treat hepatic encephalopathy. Hepatology 1996;24:337-43.
42. Gerbes AL, Waggershauser T, Holl J, Gulberg V, Fischer G, Reiser M. Experiences with novel techniques for reduction of stent flow in transjugular intrahepatic portosystemic shunts. Z Gastroenterol 1998;36:373-7.